Coya Therapeutics, Inc. (COYA) Stock Research

Coya Therapeutics, Inc.

· COYA

Dashboard

Financials

Ratios

Valuation

Statistics

117.993 M

-0.40%

Over a week ago

Coya Therapeutics announces 100th patient enrolled in Phase 2/3 ALSTARS trial

COYA

Sep 15, 8:02 AM

Coya announces publication of preclinical study on effects of COYA 303

COYA

Sep 8, 8:08 AM

Coya Therapeutics reports Q2 EPS (28c), consensus (36c)

COYA

Aug 11, 8:03 AM

Roth Capital biopharmaceuticals analyst holds a webinar

Jul 6, 5:01 PM

Coya Therapeutics initiates first cohort of patients in ALSTARS trial

COYA

Jun 8, 8:13 AM

Coya Therapeutics initiated with bullish view at Roth Capital, here's why

COYA

Jun 5, 4:18 AM

Coya Therapeutics reports Q1 EPS (32c), consensus (39c)

COYA

May 12, 7:36 AM

Coya Therapeutics granted FDA Fast Track Designation for COYA 302

COYA

May 12, 7:33 AM

Coya Therapeutics announces publication of research on COYA 302

COYA

Apr 9, 8:03 AM

Coya Therapeutics Executive Chairman Howard Berman steps down

COYA

Apr 2, 8:08 AM

Coya publishes study showing reduction in regulatory T cell function in FTD

COYA

Mar 18, 8:27 AM

Coya Therapeutics to sell 2.522M shares at $4.40 in private placement

Jan 30, 8:13 AM

Coya Therapeutics announces FDA acceptance of COYA 302 IND application

COYA

Jan 5, 8:03 AM

Coya announces Health Canada acceptance of COYA 302 clinical trial application

COYA

Dec 23, 8:05 AM

Coya Therapeutics commences dosing in ALSTARS trial

COYA

Dec 9, 8:05 AM

Coya Therapeutics reports Q3 EPS (13c), consensus (30c)

COYA

Nov 12, 8:18 AM

Coya Therapeutics price target raised by $1 at Lake Street, here's why

COYA

Nov 5, 8:48 AM

Coya Therapeutics announces results from COYA 303 in vivo animal study

COYA

Nov 4, 9:02 AM

Coya Therapeutics 3.64M Spot Secondary priced at $5.50

COYA

Oct 24, 6:33 AM

Coya Therapeutics announces common stock offering, no amount given

COYA

Oct 23, 4:33 PM

No more stories

Charts